You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Biological Therapies in Immune-Mediated Inflammatory Diseases: Can Biosimilars Reduce Access Inequities?
|
|---|---|
| Published in |
Frontiers in Pharmacology, March 2019
|
| DOI | 10.3389/fphar.2019.00279 |
| Pubmed ID | |
| Authors |
Daniel C. Baumgart, Laurent Misery, Sue Naeyaert, Peter C. Taylor |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 2 | 29% |
| United States | 1 | 14% |
| Germany | 1 | 14% |
| Austria | 1 | 14% |
| Canada | 1 | 14% |
| Unknown | 1 | 14% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 71% |
| Scientists | 2 | 29% |
Mendeley readers
The data shown below were compiled from readership statistics for 136 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 136 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 19 | 14% |
| Researcher | 15 | 11% |
| Other | 14 | 10% |
| Student > Ph. D. Student | 12 | 9% |
| Student > Bachelor | 8 | 6% |
| Other | 25 | 18% |
| Unknown | 43 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 26 | 19% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 10% |
| Biochemistry, Genetics and Molecular Biology | 6 | 4% |
| Social Sciences | 6 | 4% |
| Economics, Econometrics and Finance | 6 | 4% |
| Other | 29 | 21% |
| Unknown | 49 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 October 2022.
All research outputs
#1,435,860
of 24,083,187 outputs
Outputs from Frontiers in Pharmacology
#522
of 17,947 outputs
Outputs of similar age
#33,786
of 355,542 outputs
Outputs of similar age from Frontiers in Pharmacology
#14
of 342 outputs
Altmetric has tracked 24,083,187 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 17,947 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,542 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 342 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.